Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
21.91
-1.40 (-6.01%)
At close: Jun 5, 2026, 4:00 PM EDT
22.34
+0.43 (1.96%)
After-hours: Jun 5, 2026, 7:57 PM EDT
Ultragenyx Pharmaceutical Stock Forecast
Stock Price Forecast
According to 19 analysts polled by S&P Global, Ultragenyx Pharmaceutical stock has a consensus rating of "Strong Buy" and an average price target of $52.05. The average 1-year stock price forecast is 137.56% higher than the current stock price, while the lowest is $25 (+14.10%) and the highest is $96 (+338.16%).
Price Target: $52.05 (+137.56%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Ultragenyx Pharmaceutical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 15 | 15 | 14 | 13 | 13 | 12 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 21 | 21 | 20 | 20 | 20 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains $74 → $72 | Buy | Maintains | $74 → $72 | +228.62% | May 23, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $84 → $96 | Buy | Reiterates | $84 → $96 | +338.16% | May 21, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $34 → $33 | Buy | Maintains | $34 → $33 | +50.62% | May 11, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $79 | Buy | Maintains | $79 | +260.57% | May 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $50 | Buy | Reiterates | $50 | +128.21% | May 11, 2026 |
Financial Forecast
Revenue This Year
741.43M
from 673.00M
Increased by 10.17%
Revenue Next Year
983.59M
from 741.43M
Increased by 32.66%
EPS This Year
-4.24
from -5.83
EPS Next Year
0.97
from -4.24
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 769.1M | ||
| Avg | 741.4M | ||
| Low | 714.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 14.3% | ||
| Avg | 10.2% | ||
| Low | 6.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | -4.24 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |